Features | Partner Sites | Information | LinkXpress
Sign In
ElsMed
Samsung
Ampronix

Partners Seek to Develop New Imagining Agents for Cardiovascular Disease Diagnosis

By Medimaging International staff writers
Posted on 09 Dec 2013
Partners in a recently signed research agreement will be developing new imaging agents for the noninvasive measurement of blood flow in the heart for the diagnosis of cardiovascular diseases–a sector worth of some two billion USD annually.

Hadasit (Jerusalem, Israel), the technology transfer company of the Hadassah Medical Organization (Jerusalem, Israel) announced the initiation of a three-year license and cooperation agreement with Synektik SA (Warsaw, Poland) to develop new imagining agents for use in PET/CT scans, which will enable the quantitative measurement of blood flow to the heart. The potential agents are expected to enable the clinician to determine the extent of damage resulting from a heart attack, and predict the degree of recovery after the heart attack or bypass surgery.

Research will be conducted at the Hadassah Medical Organization in Jerusalem in cooperation with Synektik's new research and development facility in Warsaw. Development funding of four million USD will be provided by Synektik, which will receive a worldwide license for any newly developed imaging agent and will spearhead further development, clinical trials registration, and commercialization.

Dr. Eyal Mishani, director of the cyclotron and radiochemistry unit of the Hadassah Medical Organization, said, "The funding would facilitate pre-clinical research and development stages and preparation for clinical trials which will be performed jointly with Synektik."

Related Links:

Hadasit
Hadassah Medical Organization
Synektik SA



PHS Technologies
Supersonic Imagine
ARAB HEALTH

Channels

Radiography

view channel

Low-Dose CT Offers Cost-Effective Lung Screening

A new statistical analysis of from a US lung screening trial concluded that performing low-dose computed tomography (CT) screening can be cost-effective compared to doing no screening for lung cancer in aging smokers. “This provides evidence, given the assumptions we used, that it is cost-effective,” said Ilana Gareen,... Read more

MRI

view channel
Image: Differences in the brains of autistic and control subjects using MRI (Photo courtesy of Center of Cognitive Brain Imaging, Carnegie Mellon University).

MRI Shows Brain Anatomy Differences Between Autistic and Typically Developing Individuals to Be Mostly Indistinguishable

In the largest magnetic resonance imaging (MRI) study of patients with autism to date, Israeli and American researchers have shown that the brain anatomy in MRI scans of autistic individuals older than... Read more

Nuclear medicine

view channel
Image: The MRIdian MRI-guided radiation therapy system (Photo courtesy of ViewRay).

World’s First Clinical MRI-Guided Radiation Therapy System Awarded CE Marking

The world’s first magnetic resonance imaging (MRI)-guided radiation therapy system has received CE marking approval, which will allow the developer of the technology to deliver the systems throughout Europe... Read more

General/Advanced Imaging

view channel

Photoacoustic Imaging Optimizes Visualization of Cancerous Tissues Using Time Reversal Technology

Unique time-reversal technology is being used to better focus light in tissue, such as muscles and organs. Current high-resolution optical imaging technology allows researchers to see about 1-mm-deep into the body. In an effort to enhance this imaging technology, the investigators are employing photoacoustic imaging, which... Read more

Imaging IT

view channel

Imaging Data, Tools Developed for Heart Disease Research

A virtual machine is being developed to optimize reproducibility and data availability to assess and enhance analyses of magnetic resonance imaging (MRI) myocardial perfusion data. The project was described November 11, 2014, in the open access, open data journal GigaScience. The study’s researchers, from the Universidad... Read more
 

Events

01 Dec 2014 - 05 Dec 2014
11 Jan 2015 - 14 Jan 2015
Copyright © 2000-2014 Globetech Media. All rights reserved.